Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Assets Average: 2022-2025

Historic Assets Average for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $224.9 million.

  • Gossamer Bio's Assets Average fell 37.91% to $224.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.9 million, marking a year-over-year decrease of 37.91%. This contributed to the annual value of $313.6 million for FY2024, which is 7.33% up from last year.
  • Latest data reveals that Gossamer Bio reported Assets Average of $224.9 million as of Q3 2025, which was down 13.76% from $260.8 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Assets Average peaked at $362.2 million during Q3 2024, and registered a low of $200.8 million during Q2 2023.
  • Over the past 3 years, Gossamer Bio's median Assets Average value was $285.6 million (recorded in 2024), while the average stood at $283.9 million.
  • As far as peak fluctuations go, Gossamer Bio's Assets Average surged by 57.55% in 2024, and later crashed by 37.91% in 2025.
  • Gossamer Bio's Assets Average (Quarterly) stood at $298.0 million in 2022, then increased by 10.71% to $329.9 million in 2023, then grew by 0.96% to $333.1 million in 2024, then plummeted by 37.91% to $224.9 million in 2025.
  • Its Assets Average stands at $224.9 million for Q3 2025, versus $260.8 million for Q2 2025 and $297.9 million for Q1 2025.